[Initial medical treatment: beta-blockers or prostaglandins? The beta-blocker is the Swiss Army knife of the glaucoma physician].
With the emergence of prostaglandin analogs, beta-blockers have been challenged as the initial treatment for glaucoma. It should be remembered that their clinical efficacy in reducing intraocular pressure is well established, systemic passage is much lower with delayed-action forms and gel forms, compliance is excellent and all of these therapeutic advantages are provided with a particularly low cost.
Service d'Ophtalmologie, CHU Huriez, Place de Verdun, 59037 Lille Cedex.
J-F
JF
Rouland
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D005782:Gels; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D010349:Patient Compliance
D000319:Adrenergic beta-Antagonists; D003692:Delayed-Action Preparations; D005782:Gels